Article
Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.
PloS one - 1 Jan 2014
Galal Iman F, Zakaria Zainab, Allam Walaa R, Mahmoud Mohamed A, Ezzat Ahmed R, Osman Ahmed, Waked Imam, Strickland G Thomas, Abdelwahab Sayed F
Abstract excerpt
BACKGROUND: Hepatitis C Virus (HCV) infection is a global health burden particularly in Egypt, where HCV genotype 4a (GT-4a) predominates. The prevention and control of HCV infection will remain a challenge until the development of an effective vaccine that protects against different genotypes. Several HCV GT-1-based vaccines are in different stages of clinical trials, but antigenic differences could make...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
